Polymorphisms in the P450 c17 (17-Hydroxylase/17,20-Lyase) and P450 c19 (Aromatase) Genes: Association with Serum Sex Steroid Concentrations and Bone Mineral Density in Postmenopausal Women
John Somner,
Susan McLellan,
Joseph Cheung,
Y. T. Mak,
Michelle L. Frost,
Karen M. Knapp,
Anthony S. Wierzbicki,
Michael Wheeler,
Ignac Fogelman,
Stuart H. Ralston and
Geeta N. Hampson
Department of Chemical Pathology, St. Thomas Hospital (J.S., S.M., J.C., Y.T.M., A.S.W., M.W., G.N.H.), London, SE1 7EH United Kingdom; Osteoporosis Screening Unit, Guys Hospital (M.L.F., K.M.K., I.F.), London SE1 9RT United Kingdom; and Bone Research Group, Department of Medicine and Therapeutics, University of Aberdeen Medical School (S.H.R.), Aberdeen, AB25 2ZD United Kingdom
Address all correspondence and requests for reprints to: Geeta N. Hampson, M.D., Department of Chemical Pathology, 5th Floor, North Wing, St. Thomas Hospital, London, United Kingdom SE1 7 EH. E-mail: geeta.hampson{at}kcl.ac.uk.
The CYP 17 and CYP 19 genes encode 17-hydroxylase/17,20-lyaseand aromatase, respectively, both involved in sex hormone synthesis.We investigated the association between 2 common polymorphismsin 1) the promoter region (TC substitution) of CYP 17, and 2)exon 3 (GA) of CYP 19, bone mineral density (BMD) and serumandrogen/estradiol, in a case-control study of 252 postmenopausalwomen aged 64.5 ± 9.2 yr (mean ± SD). There wasno significant difference in serum estradiol concentrationsbetween cases (n = 136) and controls (n = 116). The CYP 19 genotypewas significantly associated with serum estradiol (P = 0.002).Women with the AA genotype had higher serum estradiol concentrationscompared with those with the GG genotype (P = 0.03). In olderwomen, those with the CYP 19 GA and GG genotypes had an increasedprevalence of osteoporosis (P = 0.04) and fractures (P = 0.003).We found no significant association between CYP 17 genotypeand serum androgens and estradiol concentrations. However, asignificant association was seen between BMD values at the femoralneck with CYP 17 genotype in cases (P = 0.04) and in the wholestudy population (P = 0.012). Subjects with the CC genotypehad significantly lower BMD (mean ± SD: TT, 0.7 ±0.16; CC, 0.6 ± 0.08 g/cm2; P = 0.006). In conclusion,both CYP 17 and CYP 19 are candidate genes for osteoporosisin postmenopausal women.
Abbreviations: BMD, Bone mineral density; BMI, body mass index;CV, coefficient of variation; DHEAS, dehydroepiandrosteronesulfate; DXA, dual energy x-ray absorptiometry; LN, naturallogarithm; SNP, single nucleotide polymorphism.
This article has been cited by other articles:
B. M. TUZUNER, T. OZTURK, H. I. KISAKESEN, S. ILVAN, C. ZERRIN, O. OZTURK, and T. ISBIR CYP17 (T-34C) and CYP19 (Trp39Arg) Polymorphisms and their Cooperative Effects on Breast Cancer Susceptibility
In Vivo,
January 1, 2010;
24(1):
71 - 74.
[Abstract][Full Text][PDF]
X. Wang, D. J. Tomso, B. N. Chorley, H.-Y. Cho, V. G. Cheung, S. R. Kleeberger, and D. A. Bell Identification of polymorphic antioxidant response elements in the human genome
Hum. Mol. Genet.,
May 15, 2007;
16(10):
1188 - 1200.
[Abstract][Full Text][PDF]
J. A. Riancho, C. Valero, A. Naranjo, D. J. Morales, C. Sanudo, and M. T. Zarrabeitia Identification of an Aromatase Haplotype That Is Associated with Gene Expression and Postmenopausal Osteoporosis
J. Clin. Endocrinol. Metab.,
February 1, 2007;
92(2):
660 - 665.
[Abstract][Full Text][PDF]
S. H. Olson, E. V. Bandera, and I. Orlow Variants in Estrogen Biosynthesis Genes, Sex Steroid Hormone Levels, and Endometrial Cancer: A HuGE Review
Am. J. Epidemiol.,
February 1, 2007;
165(3):
235 - 245.
[Abstract][Full Text][PDF]
M. T Zarrabeitia, J. L Hernandez, C. Valero, A. Zarrabeitia, J. A Amado, J. Gonzalez-Macias, and J. A Riancho Adiposity, estradiol, and genetic variants of steroid-metabolizing enzymes as determinants of bone mineral density
Eur. J. Endocrinol.,
January 1, 2007;
156(1):
117 - 122.
[Abstract][Full Text][PDF]
J. A Riancho, M. T Zarrabeitia, C. Valero, C. Sanudo, V. Mijares, and J. Gonzalez-Macias A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density.
Eur. J. Endocrinol.,
July 1, 2006;
155(1):
53 - 59.
[Abstract][Full Text][PDF]
N. Tsuchiya, L. Wang, H. Suzuki, T. Segawa, H. Fukuda, S. Narita, M. Shimbo, T. Kamoto, K. Mitsumori, T. Ichikawa, et al. Impact of IGF-I and CYP19 Gene Polymorphisms on the Survival of Patients With Metastatic Prostate Cancer
J. Clin. Oncol.,
May 1, 2006;
24(13):
1982 - 1989.
[Abstract][Full Text][PDF]
C. X. Ma, A. A. Adjei, O. E. Salavaggione, J. Coronel, L. Pelleymounter, L. Wang, B. W. Eckloff, D. Schaid, E. D. Wieben, A. A. Adjei, et al. Human Aromatase: Gene Resequencing and Functional Genomics
Cancer Res.,
December 1, 2005;
65(23):
11071 - 11082.
[Abstract][Full Text][PDF]
C. J. Petry, K. K. Ong, K. F. Michelmore, S. Artigas, D. L. Wingate, A. H. Balen, F. de Zegher, L. Ibanez, and D. B. Dunger Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women
Hum. Reprod.,
July 1, 2005;
20(7):
1837 - 1843.
[Abstract][Full Text][PDF]
H. Z. Ring, C. N. Lessov, T. Reed, R. Marcus, L. Holloway, G. E. Swan, and D. Carmelli Heritability of Plasma Sex Hormones and Hormone Binding Globulin in Adult Male Twins
J. Clin. Endocrinol. Metab.,
June 1, 2005;
90(6):
3653 - 3658.
[Abstract][Full Text][PDF]
I. M. Dick, A. Devine, and R. L. Prince Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women
Am J Physiol Endocrinol Metab,
May 1, 2005;
288(5):
E989 - E995.
[Abstract][Full Text][PDF]
N. C. Onland-Moret, C. H. van Gils, M. Roest, D. E. Grobbee, and P. H.M. Peeters Cyp17, Urinary Sex Steroid Levels and Breast Cancer Risk in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev.,
April 1, 2005;
14(4):
815 - 820.
[Abstract][Full Text][PDF]
R. C. Travis, M. Churchman, S. A. Edwards, G. Smith, P. K. Verkasalo, C. R. Wolf, H. Wolf, and T. J. Key No Association of Polymorphisms in CYP17, CYP19, and HSD17-B1 with Plasma Estradiol Concentrations in 1,090 British Women
Cancer Epidemiol. Biomarkers Prev.,
December 1, 2004;
13(12):
2282 - 2284.
[Full Text][PDF]
L. Gennari, R. Nuti, and J. P. Bilezikian Aromatase Activity and Bone Homeostasis in Men
J. Clin. Endocrinol. Metab.,
December 1, 2004;
89(12):
5898 - 5907.
[Abstract][Full Text][PDF]